Trial · NCT03231306
Adverse events214
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 214
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Open Label Study of Binimetinib (MEK162) | 16 | 45 | 36 |
| other | Cardiac disorders - Other, Non-Specific St And T-Wave Abnormalities | Cardiac disorders | Open Label Study of Binimetinib (MEK162) | 1 | 45 | 1 |
| other | Cardiac disorders - Other, Nonspecific T Wave Abnormality | Cardiac disorders | Open Label Study of Binimetinib (MEK162) | 1 | 45 | 1 |
| other | Cardiac disorders - Other, Specify, Electrocardiogram T Wave Abnormal | Cardiac disorders | Open Label Study of Binimetinib (MEK162) | 2 | 45 | 2 |
| other | Cardiac disorders - Other, Systolic Murmur | Cardiac disorders | Open Label Study of Binimetinib (MEK162) | 1 | 45 | 1 |
| other | Cardiac disorders - Other, Tachycardia | Cardiac disorders | Open Label Study of Binimetinib (MEK162) | 1 | 45 | 1 |
| other | Conduction disorder | Cardiac disorders | Open Label Study of Binimetinib (MEK162) | 1 | 45 | 1 |
| other | Pulmonary Valve Disease | Cardiac disorders | Open Label Study of Binimetinib (MEK162) | 1 | 45 | 1 |
| other | Sinus bradycardia | Cardiac disorders | Open Label Study of Binimetinib (MEK162) | 1 | 45 | 1 |
| other | Sinus tachycardia | Cardiac disorders | Open Label Study of Binimetinib (MEK162) | 4 | 45 | 8 |
| other | Ventricular Arrhythmia | Cardiac disorders | Open Label Study of Binimetinib (MEK162) | 1 | 45 | 1 |
| other | Ear and labyrinth disorders - Other, Mastoid Effusion | Ear and labyrinth disorders | Open Label Study of Binimetinib (MEK162) | 1 | 45 | 1 |
| other | External Ear Inflammation | Ear and labyrinth disorders | Open Label Study of Binimetinib (MEK162) | 1 | 45 | 1 |
| other | Endocrine disorders - Other, Increased Intolerance To Heat And Humidity | Endocrine disorders | Open Label Study of Binimetinib (MEK162) | 1 | 45 | 1 |
| other | Blurred Vision | Eye disorders | Open Label Study of Binimetinib (MEK162) | 2 | 45 | 3 |
| other | Conjunctivitis | Eye disorders | Open Label Study of Binimetinib (MEK162) | 2 | 45 | 2 |
| other | Corneal ulcer | Ear and labyrinth disorders | Open Label Study of Binimetinib (MEK162) | 1 | 45 | 1 |
| other | Dry Eye | Eye disorders | Open Label Study of Binimetinib (MEK162) | 1 | 45 | 1 |
| other | Eye disorders - Other, Blepharitis | Eye disorders | Open Label Study of Binimetinib (MEK162) | 1 | 45 | 1 |
| other | Eye disorders - Other, Central Lenticular Opacities | Eye disorders | Open Label Study of Binimetinib (MEK162) | 1 | 45 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03231306/events